TMCnet News
Visceral Pain Pipeline Report, H2 2017 - Therapeutics Review of 10 Companies & Drug Profiles - Research and MarketsThe "Visceral Pain - Pipeline Review, H2 2017" report has been added to Research and Markets' offering. Pharmaceutical and Healthcare latest pipeline guide Visceral Pain - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Visceral Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Visceral Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Visceral Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, IND/CTA Filed and Preclinical stages are 1, 1 and 11 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively. Visceral Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/research/mxz6hk/visceral_pain
View source version on businesswire.com: http://www.businesswire.com/news/home/20170818005225/en/ |
